These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1575009)

  • 21. Malignancy markers in the cerebrospinal fluid.
    Koskiniemi M
    Eur J Pediatr; 1988 Oct; 148(1):3-8. PubMed ID: 3058481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
    Chang CS; Liu HW; Lin SF; Chen TP
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia).
    Crespo-Solis E; López-Karpovitch X; Higuera J; Vega-Ramos B
    Curr Oncol Rep; 2012 Oct; 14(5):369-78. PubMed ID: 22639108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma.
    Hooijkaas H; Hählen K; Adriaansen HJ; Dekker I; van Zanen GE; van Dongen JJ
    Blood; 1989 Jul; 74(1):416-22. PubMed ID: 2752121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
    Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
    Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
    Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
    Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia.
    Asami T; Tanaka A; Gunji T; Sakai K; Asami K
    Acta Paediatr Scand; 1987 Mar; 76(2):260-5. PubMed ID: 3296627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
    Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibronectin concentration in cerebrospinal fluid reflects early central nervous system involvement in children with acute lymphoblastic leukemia.
    Koskiniemi M; Rajantie J; Rautonen J; Laipio ML; Salonen EM; Siimes MA; Vaheri A
    Leuk Res; 1990; 14(5):449-52. PubMed ID: 2345467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unreliability of beta-2-microglobulin in early detection of central nervous system relapse in acute lymphoblastic leukemia.
    Nagelkerke AF; van Kamp GJ; Veerman AJ; de Waal FC
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):659-63. PubMed ID: 3894031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
    Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
    Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
    [No Abstract]   [Full Text] [Related]  

  • 34. The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.
    Mabray MC; Barajas RF; Villanueva-Meyer JE; Zhang CA; Valles FE; Rubenstein JL; Cha S
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):74-9. PubMed ID: 26381553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central nervous disease in pediatric patients during acute lymphoblastic leukemia (ALL): a review.
    Jin MW; Xu SM; An Q
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6015-6019. PubMed ID: 30280785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid immunoglobulins and beta 2-microglobulin in lymphoproliferative and other neoplastic diseases of the central nervous system.
    Ernerudh J; Olsson T; Berlin G; von Schenck H
    Arch Neurol; 1987 Sep; 44(9):915-20. PubMed ID: 3304227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid ferritin in patients with leukaemia and malignant lymphoma.
    Milman N; Vig L; Pedersen NS; Olsen TS
    Scand J Haematol; 1985 Aug; 35(2):132-6. PubMed ID: 3863234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
    Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
    Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia.
    Lee W; Kim SJ; Lee S; Kim J; Kim M; Lim J; Kim Y; Cho B; Lee EJ; Han K
    Ann Clin Lab Sci; 2005; 35(4):407-12. PubMed ID: 16254256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.